These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 10721636)

  • 21. [Differentiated treatment of diabetics with an acute coronary syndrome].
    Hamm CW; Hamann A
    Dtsch Med Wochenschr; 2006 Nov; 131(47 Suppl 7):S208-10. PubMed ID: 17109250
    [No Abstract]   [Full Text] [Related]  

  • 22. Transfer with GP IIb/IIIa inhibitor tirofiban for primary percutaneous coronary intervention vs. on-site thrombolysis in patients with ST-elevation myocardial infarction (STEMI): a randomized open-label study for patients admitted to community hospitals.
    Dobrzycki S; Kralisz P; Nowak K; Prokopczuk P; Kochman W; Korecki J; Poniatowski B; Zuk J; Sitniewska E; Bachorzewska-Gajewska H; Sienkiewicz J; Musial WJ
    Eur Heart J; 2007 Oct; 28(20):2438-48. PubMed ID: 17884846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multimodality reperfusion therapy for acute myocardial infarction.
    Cannon CP
    Am Heart J; 2000 Nov; 140(5):707-16. PubMed ID: 11054614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antithrombotic treatment of NSTEMI/UAP. The interaction with PCI.
    Otterstad JE; Brosstad F
    Scand Cardiovasc J; 2004 Mar; 38(1):9-15. PubMed ID: 15204241
    [No Abstract]   [Full Text] [Related]  

  • 25. Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction.
    Collins R; Peto R; Baigent C; Sleight P
    N Engl J Med; 1997 Mar; 336(12):847-60. PubMed ID: 9062095
    [No Abstract]   [Full Text] [Related]  

  • 26. [Risk stratification in the acute coronary syndrome. Diabetes--a diagnostic dilemma].
    Giannitsis E; Katus HA
    Dtsch Med Wochenschr; 2006 Nov; 131(47 Suppl 7):S211-4. PubMed ID: 17109251
    [No Abstract]   [Full Text] [Related]  

  • 27. Antithrombotics and antiplatelets in acute myocardial infarction.
    Wander GS; Gupta NK
    Indian Heart J; 2011; 63(1):58-65. PubMed ID: 23189866
    [No Abstract]   [Full Text] [Related]  

  • 28. Platelet disaggregation: putting time on your side in acute myocardial infarction.
    Simon DI; Sakuma M
    J Am Coll Cardiol; 2004 Jul; 44(2):324-6. PubMed ID: 15261926
    [No Abstract]   [Full Text] [Related]  

  • 29. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial.
    Pereira H;
    Rev Port Cardiol; 2001 Jun; 20(6):687-8. PubMed ID: 11525077
    [No Abstract]   [Full Text] [Related]  

  • 30. [Combination therapy for acute myocardial infarction with glycoprotein IIb/IIIa inhibitors and fibrinolysis].
    Vandoni P; Poli A; Fetiveau R; Cafiero F; D'Urbano M; De Servi S
    Ital Heart J Suppl; 2002 May; 3(5):539-43. PubMed ID: 12064193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The efficacy and safety of combination glycoprotein IIbIIIa inhibitors and reduced-dose thrombolytic therapy-facilitated percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized clinical trials.
    Sinno MC; Khanal S; Al-Mallah MH; Arida M; Weaver WD
    Am Heart J; 2007 Apr; 153(4):579-86. PubMed ID: 17383297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glycoprotein IIb/IIIa antagonism and fibrinolytic therapy for acute myocardial infarction.
    Vivekananthan DP; Patel VB; Moliterno DJ
    J Interv Cardiol; 2002 Apr; 15(2):131-9. PubMed ID: 12063808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmacological reperfusion in acute myocardial infarct].
    Lorenzoni R; Gensini GF; De Caterina R
    G Ital Cardiol; 1998 Dec; 28(12):1441-55. PubMed ID: 9887401
    [No Abstract]   [Full Text] [Related]  

  • 34. Percutaneous coronary intervention versus thrombolysis: the definite management of st elevation myocardial infarction.
    Martinez-Ojeda J; Martinez-Toro J
    Bol Asoc Med P R; 2005; 97(4):308-14. PubMed ID: 16599071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycoprotein IIb/IIIa receptor inhibitors in acute ST-elevation myocardial infarction: will the combination with thrombolytics become reality?
    Zeymer U
    J Thromb Thrombolysis; 2003 Apr; 15(2):91-7. PubMed ID: 14618075
    [No Abstract]   [Full Text] [Related]  

  • 36. Safety and efficacy of thrombolysis with alteplase (50 mg) plus tirofiban versus alteplase (100 mg) alone in acute myocardial infarction: preliminary findings.
    Sarullo FM; Pasquale PD; D'Alfonso G; Amerigo L; Cannizzaro S; Castello A
    Ital Heart J; 2001 Aug; 2(8):605-11. PubMed ID: 11577835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Challenging the conclusions drawn in "Thrombolysis for acute myocardial infarction: drug review".
    Howlett M
    MedGenMed; 2002 Feb; 4(1):6; author reply 7. PubMed ID: 11965208
    [No Abstract]   [Full Text] [Related]  

  • 38. Tirofiban-induced coronary thrombolysis.
    Jayasundera TG; Feldman DN; Marmur JD
    J Invasive Cardiol; 1999 Mar; 11(3):138-40. PubMed ID: 10745501
    [No Abstract]   [Full Text] [Related]  

  • 39. Adjunctive therapies in the cath lab. Combination of tirofiban and alteplase in acute myocardial infarction.
    Arjomand H; Sokil AB; Arjmand R; Fischer HA; Wolf NM
    J Invasive Cardiol; 2001 Sep; 13(9):647-50. PubMed ID: 11533504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrating GP IIb/IIIa inhibition into treatment strategies for acute ST-elevation myocardial infarction.
    Kandzari DE; Roe MT
    J Invasive Cardiol; 2002 Sep; 14(9):565-74. PubMed ID: 12205361
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.